Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers - 18/03/21
, Rosemary J. Boyton d, Cliomar Alves dos Santos e, Camilla Natália Oliveira Santos f, Juliana Cardoso Alves f, Ianaline Lima Santos f, Lucas Sousa Magalhães f, Emilia M.M.A. Belitardo g, Danilo J.P.G. Rocha g, João P.P. Almeida h, Luis G.C. Pacheco g, Eric R.G.R. Aguiar i, Gubio Soares Campos j, Silvia Inês Sardi j, Rejane Hughes Carvalho j, Amélia Ribeiro de Jesus a, f, 2, Karla Freire Rezende a, 2, Roque Pacheco de Almeida a, f, 2, ⁎
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | We describe 33 patients with recurrent COVID19 and a positive PCR. |
• | Recurrence is associated with working as a healthcare professional, blood-group A, and low IgG response to infection. |
• | Evidence from differential virus sequencing between the first and second episode supports de novo reinfection. |
• | Recurrent episodes tended to be more severe, with one fatal infection. |
Summary |
Background |
There is growing concern about individuals reported to suffer repeat COVID-19 disease episodes, these in a small number of cases characterised as de novo infections with distinct sequences, indicative of insufficient protective immunity even in the short term.
Methods |
Observational case series and case-control studies reporting 33 cases of recurrent, symptomatic, qRT-PCR positive COVID-19. Recurrent disease was defined as symptomatic recurrence after symptom-free clinical recovery, with release from isolation >14 days from the beginning of symptoms confirmed by qRT-PCR. The case control study-design compared this group of patients with a control group of 62 patients randomly selected from the same COVID-19 database.
Results |
Of 33 recurrent COVID-19 patients, 26 were female and 30 were HCW. Mean time to recurrence was 50.5 days which was associated with being a HCW (OR 36.4 (p <0.0001)), and blood type A (OR 4.8 (p = 0.002)). SARS-CoV-2 antibodies were signifcantly lower in recurrent patients after initial COVID-19 (2.4 ± 0.610; p<0.0001) and after recurrence (6.4 ± 11.34; p = 0.007). Virus genome sequencing identified reinfection by a different isolate in one patient.
Conclusions |
This is the first detailed case series showing COVID-19 recurrence with qRT-PCR positivity. For one individual detection of phylogenetically distinct genomic sequences in the first and second episodes confirmed bona fide renfection, but in most cases the data do not formally distinguish between reinfection and re-emergence of a chronic infection reservoir. These episodes were significantly associated with reduced Ab response during initial disease and argue the need for ongoing vigilance without an assumption of protection after a first episode.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Keywords : COVID-19, Recurrence, Reinfection, SARS-CoV-2, Antibodies
Plan
Vol 82 - N° 3
P. 399-406 - mars 2021 Retour au numéro
Article précédent
- Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care
- Oana Bulilete, Patricia Lorente, Alfonso Leiva, Eugenia Carandell, Antonio Oliver, Estrella Rojo, Pau Pericas, Joan Llobera, COVID-19 Primary Care Research Group
- Emergence of a non vaccine-cognate enterovirus A71 genotype C1 in mainland China
- Hanri Zeng, Lina Yi, Xiaoli Chen, Huiqiong Zhou, Huanying Zheng, Jing Lu, Fen Yang, Caixia Li, Ling Fang, Xin Zhang, Xu Jing, Jie Wu, Hui Li
Bienvenue sur EM-consulte, la référence des professionnels de santé.